Indian pharma ramps up US acquisitions amid regulatory and market shifts
Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...
The Financial Express2d
India’s pharma industry betting big on CDMO opportunity – All you need to know
India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...
Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
US tariffs on India will be a bitter pill to swallow
Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...
India’s Generic Pharma Boom: What’s Next for the Industry?
Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...
India’s Pharma Industry Raises Concerns Of Shortage & Costlier Medicine For Americans Over Proposed US Tariffs
Industry leaders warn that potential US tariffs on Indian pharmaceutical exports could increase drug costs for American ...
CNBCTV182d
US tariffs on Indian pharma will be hard to implement & inflationary: Systematix’s Vishal Manchanda
Vishal Manchanda, Pharma Analyst at Systematix Group, stated that Sun Pharmaceutical stands to gain significantly from its recent acquisition of Checkpoint Therapeutics, as it provides access to the ...
Singapore Armodafinil hospitalisation: Indian pharma company claims ‘never supplied drug outside country’
Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...
Pharmabiz4h
Sparsha Pharma transforming drug delivery with cutting-edge transdermal innovations: Dr Veerapaneni
Sparsha Pharma transforming drug delivery with cutting-edge transdermal innovations: Dr Veerapaneni: Shardul Nautiyal, Mumbai Saturday, March 15, 2025, 08:00 Hrs [IST] Sparsha Pha ...
India's Sun Pharma aims to launch its obesity drug in five years, managing director says
India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...
India’s pharma R&D to attract ₹17,000 crore investment by FY28: Amit Agrawal, Pharma Secretary
India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.